Compare $MPLT vs $NGNE | Chartloom

Compare

$MPLT vs $NGNE

MapLight Therapeutics Inc · Neurogene Inc

MPLT

MapLight Therapeutics Inc

NGNE

Neurogene Inc

Compare $MPLT vs $NGNE

Comparing MapLight Therapeutics Inc and Neurogene Inc

MPLTMapLight Therapeutics Inc

NGNENeurogene Inc

MPLTMapLight Therapeutics Inc

Market cap

$400M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-47.3%

52W performance

-51.9%

FCF yield

-43.7%

NGNENeurogene Inc

Market cap

$521M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

31.0%

52W performance

2.2%

FCF yield

-16.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

MPLT

NGNE

Detailed metrics comparison

MPLT

MapLight Therapeutics Inc

NGNE

Neurogene Inc

Market Cap

MPLT$400M

NGNE$521M

Enterprise Value

MPLT$329M

NGNE$409M

Price

MPLT$8.83

NGNE$26.40

P/E Ratio

MPLTN/A

NGNEN/A

P/S Ratio

MPLT0.00x

NGNE0.00x

EV/Sales

MPLT0.00x

NGNE0.00x

EV/EBITDA

MPLT0.00x

NGNE0.00x

P/B Ratio

MPLT1.57x

NGNE2.36x

P/FCF Ratio

MPLTN/A

NGNEN/A

EV/FCF

MPLT-1.88x

NGNE-4.66x

PEG Ratio

MPLTN/A

NGNEN/A

Forward P/E (NTM)

MPLTN/A

NGNEN/A

Forward P/S (NTM)

MPLTN/A

NGNEN/A

Revenue (TTM)

MPLT$0

NGNE$0

Revenue Growth (YoY)

MPLTN/A

NGNEN/A

Forward Rev Growth

MPLT949.5%

NGNE127.3%

Gross Margin (TTM)

MPLT0.0%

NGNE0.0%

Operating Margin (TTM)

MPLT0.0%

NGNE0.0%

EBITDA Margin (TTM)

MPLT0.0%

NGNE0.0%

Net Margin (TTM)

MPLT0.0%

NGNE0.0%

FCF Margin (TTM)

MPLTN/A

NGNEN/A

Net Income (TTM)

MPLT$-230M

NGNE$-46M

FCF (TTM)

MPLT$-175M

NGNE$-88M

EPS (TTM)

MPLT-$5.06

NGNE$0.00

ROE (TTM)

MPLT-6384.0%

NGNE-2527.0%

ROA (TTM)

MPLT-6033.0%

NGNE-2325.0%

ROIC (TTM)

MPLT-6384.0%

NGNE-2527.0%

Cash

MPLT$72M

NGNE$112M

Debt

MPLT$0

NGNE$8K

Net Cash/Debt

MPLT$72M

NGNE$112M

Current Ratio (TTM)

MPLT16.52x

NGNE10.64x

Quick Ratio (TTM)

MPLT15.79x

NGNE10.53x

Debt/Equity (TTM)

MPLT0.00x

NGNE0.00x

Debt/Assets (TTM)

MPLT0.0%

NGNE0.0%

Interest Coverage (TTM)

MPLTN/A

NGNEN/A

Net Debt/EBITDA (TTM)

MPLT0.00x

NGNE0.00x

Beta

MPLT0.85

NGNE1.71

52W Performance

MPLT-51.9%

NGNE2.2%

YTD Performance

MPLT-47.3%

NGNE31.0%

% from 52W High

MPLT-78.2%

NGNE-39.5%

% from 52W Low

MPLT1.5%

NGNE65.7%

Asset Turnover (TTM)

MPLT0.00x

NGNE0.00x

FCF Yield (TTM)

MPLT-43.7%

NGNE-16.8%

Earnings Yield (TTM)

MPLT-57.4%

NGNE-8.8%

Dividend Yield (TTM)

MPLTN/A

NGNEN/A

Rule of 40

MPLT0.0

NGNE0.0

EV/GP/RG

MPLTN/A

NGNEN/A

Ticker research

View MPLT research View NGNE research

Metric	MPLT MapLight Therapeutics Inc	NGNE Neurogene Inc
Market & Valuation
Market Cap	$400M	$521M
Enterprise Value	$329M	$409M
Price	$8.83	$26.40
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.57x	2.36x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.88x	-4.66x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	949.5%	127.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-230M	$-46M
FCF (TTM)	$-175M	$-88M
EPS (TTM)	-$5.06	$0.00
ROE (TTM)	-6384.0%	-2527.0%
ROA (TTM)	-6033.0%	-2325.0%
ROIC (TTM)	-6384.0%	-2527.0%
Financial Health
Cash	$72M	$112M
Debt	$0	$8K
Net Cash/Debt	$72M	$112M
Current Ratio (TTM)	16.52x	10.64x
Quick Ratio (TTM)	15.79x	10.53x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.85	1.71
52W Performance	-51.9%	2.2%
YTD Performance	-47.3%	31.0%
% from 52W High	-78.2%	-39.5%
% from 52W Low	1.5%	65.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-43.7%	-16.8%
Earnings Yield (TTM)	-57.4%	-8.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View MPLT research	View NGNE research

Valuation

P/S Ratio

MPLT

0.00x

NGNE

0.00x

EV/FCF

NGNE

-4.66x

MPLT

-1.88x

Growth & revenue

Forward Revenue Growth

MPLT

949.5%

NGNE

127.3%

Profitability & performance

Gross Margin

MPLT

0.0%

NGNE

0.0%

ROE

NGNE

-2527.0%

MPLT

-6384.0%

FCF Yield %

NGNE

-16.8%

MPLT

-43.7%

52-Week Performance

NGNE

2.2%

MPLT

-51.9%

Detailed metrics comparison

MPLT

MapLight Therapeutics Inc

NGNE

Neurogene Inc

Market Cap

MPLT$400M

NGNE$521M

Enterprise Value

MPLT$329M

NGNE$409M

Price

MPLT$8.83

NGNE$26.40

P/E Ratio

MPLTN/A

NGNEN/A

P/S Ratio

MPLT0.00x

NGNE0.00x

EV/Sales

MPLT0.00x

NGNE0.00x

EV/EBITDA

MPLT0.00x

NGNE0.00x

P/B Ratio

MPLT1.57x

NGNE2.36x

P/FCF Ratio

MPLTN/A

NGNEN/A

EV/FCF

MPLT-1.88x

NGNE-4.66x

PEG Ratio

MPLTN/A

NGNEN/A

Forward P/E (NTM)

MPLTN/A

NGNEN/A

Forward P/S (NTM)

MPLTN/A

NGNEN/A

Revenue (TTM)

MPLT$0

NGNE$0

Revenue Growth (YoY)

MPLTN/A

NGNEN/A

Forward Rev Growth

MPLT949.5%

NGNE127.3%

Gross Margin (TTM)

MPLT0.0%

NGNE0.0%

Operating Margin (TTM)

MPLT0.0%

NGNE0.0%

EBITDA Margin (TTM)

MPLT0.0%

NGNE0.0%

Net Margin (TTM)

MPLT0.0%

NGNE0.0%

FCF Margin (TTM)

MPLTN/A

NGNEN/A

Net Income (TTM)

MPLT$-230M

NGNE$-46M

FCF (TTM)

MPLT$-175M

NGNE$-88M

EPS (TTM)

MPLT-$5.06

NGNE$0.00

ROE (TTM)

MPLT-6384.0%

NGNE-2527.0%

ROA (TTM)

MPLT-6033.0%

NGNE-2325.0%

ROIC (TTM)

MPLT-6384.0%

NGNE-2527.0%

Cash

MPLT$72M

NGNE$112M

Debt

MPLT$0

NGNE$8K

Net Cash/Debt

MPLT$72M

NGNE$112M

Current Ratio (TTM)

MPLT16.52x

NGNE10.64x

Quick Ratio (TTM)

MPLT15.79x

NGNE10.53x

Debt/Equity (TTM)

MPLT0.00x

NGNE0.00x

Debt/Assets (TTM)

MPLT0.0%

NGNE0.0%

Interest Coverage (TTM)

MPLTN/A

NGNEN/A

Net Debt/EBITDA (TTM)

MPLT0.00x

NGNE0.00x

Beta

MPLT0.85

NGNE1.71

52W Performance

MPLT-51.9%

NGNE2.2%

YTD Performance

MPLT-47.3%

NGNE31.0%

% from 52W High

MPLT-78.2%

NGNE-39.5%

% from 52W Low

MPLT1.5%

NGNE65.7%

Asset Turnover (TTM)

MPLT0.00x

NGNE0.00x

FCF Yield (TTM)

MPLT-43.7%

NGNE-16.8%

Earnings Yield (TTM)

MPLT-57.4%

NGNE-8.8%

Dividend Yield (TTM)

MPLTN/A

NGNEN/A

Rule of 40

MPLT0.0

NGNE0.0

EV/GP/RG

MPLTN/A

NGNEN/A

Ticker research

View MPLT research View NGNE research

Metric	MPLT MapLight Therapeutics Inc	NGNE Neurogene Inc
Market & Valuation
Market Cap	$400M	$521M
Enterprise Value	$329M	$409M
Price	$8.83	$26.40
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.57x	2.36x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.88x	-4.66x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	949.5%	127.3%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-230M	$-46M
FCF (TTM)	$-175M	$-88M
EPS (TTM)	-$5.06	$0.00
ROE (TTM)	-6384.0%	-2527.0%
ROA (TTM)	-6033.0%	-2325.0%
ROIC (TTM)	-6384.0%	-2527.0%
Financial Health
Cash	$72M	$112M
Debt	$0	$8K
Net Cash/Debt	$72M	$112M
Current Ratio (TTM)	16.52x	10.64x
Quick Ratio (TTM)	15.79x	10.53x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.85	1.71
52W Performance	-51.9%	2.2%
YTD Performance	-47.3%	31.0%
% from 52W High	-78.2%	-39.5%
% from 52W Low	1.5%	65.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-43.7%	-16.8%
Earnings Yield (TTM)	-57.4%	-8.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View MPLT research	View NGNE research